Is LABT diluting shareholders?

Read three numbers together: shares outstanding over time (2.4M as of 2026-08-03), warrants that can convert into new shares, and how much cash runway remains. A company short on cash with live registrations is structurally likely to issue shares.

Where do these numbers come from?

SEC EDGAR only: the XBRL company-facts API for shares, warrants and cash, and filing metadata for registrations and pricings. Every figure shows its source form, and nothing here is estimated by us beyond the arithmetic stated next to it.

Why might a warrant tranche be missing from the table?

The tranche table is built from the dimensions the company tagged in its own 10-Q or 10-K XBRL. A tranche the filer chose not to dimension does not appear, and its absence proves nothing: the exhibits remain the ground truth. Everything shown carries the filing it came from.

Dilution profile // every instrument, one screen, from SEC filings

Lakewood-Amedex Biotherapeutics Inc. (LABT)

CIK 2079272 · all EDGAR filings →

Overall dilution risk

HIGHworst of 2 computed signals (offering ability)

= the worst band among the computed sub-ratings, no hidden weighting

not every sub-rating was computable; treat as a floor

Offering ability

HIGH$76.3M registered

= total registered offering amount from the fee exhibits of live registrations (bands: $1M / $20M)

registered capacity, not remaining: amounts already taken down are not subtracted yet

Overhead supply

NOT COMPUTEDno warrant count tagged in XBRL

= warrant shares outstanding divided by current shares outstanding

absence of a tag is not proof of absence of warrants

Historical dilution

LOW-66% O/S in 3y

= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative

a reverse-split-sized cliff is in this window; read the chart

Cash need

NOT COMPUTEDrunway not computable from latest facts

= cash vs trailing operating burn

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

Latest: 2.4M shares as of Aug 3, 2026 (10-Q). Share count fell from 7.0M to 2.4M between Mar 31, 2026 and Aug 3, 2026, a pattern consistent with a reverse split (roughly 1-for-3); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.

Cash runway

Going-concern warning

auditor flagged substantial doubt

The company itself flagged going-concern doubt in a filing.

Full breakdown: cash runway tool · source filing →

Warrants

Tranche	Warrants	Exercise price	Term	Notes
Warrant	not tagged	$100	—	—

Tranches exactly as the company dimensioned them in its 10-Q filed Aug 14, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.

No warrant figures tagged in this filer’s XBRL facts. That means the company has not reported them in structured form; it does not prove no warrants exist. The exhibits are the ground truth.

Convertible notes

Convertible debt on the balance sheet: $1.5M as of Apr 23, 2026, tagged only as a company-wide total.

This filer tagged totals without per-note dimensions in its 10-Q filed Aug 14, 2026 →, so per-note terms (maturities, individual conversion prices) live in the exhibit prose and are not parsed here.

Registrations and offerings

Registered offering capacity on live registrations: $76.3Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted

S-1May 1, 2026$29.4M registeredfiling →

S-1Jan 9, 2026$46.9M registeredfiling →

Last 12 months: 2 executed · 7 registered.

UPDATEJun 22, 2026Prospectus update — often a resale registration, not necessarily new capital424B3 →

UPDATEMay 26, 2026Prospectus update — often a resale registration, not necessarily new capital424B3 →

EXECUTEDMay 14, 2026Final prospectus — offering priced (typical for IPOs and marketed share deals)424B4 →

EFFECTIVEMay 13, 2026SEC declared a registration effective — selling can beginEFFECT →

REGISTEREDMay 1, 2026S-1 registration — capacity to sell shares, not a sale yetS-1 →

UPDATEApr 30, 2026Prospectus update — often a resale registration, not necessarily new capital424B3 →

EXECUTEDApr 23, 2026Final prospectus — offering priced (typical for IPOs and marketed share deals)424B4 →

EFFECTIVEApr 17, 2026SEC declared a registration effective — selling can beginEFFECT →

REGISTEREDApr 6, 2026S-1/A registration — capacity to sell shares, not a sale yetS-1/A →

REGISTEREDApr 1, 2026S-1/A registration — capacity to sell shares, not a sale yetS-1/A →

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full LABT workspace